The key focus of Jakob & Partners is pharmaceutical market timings - the timings of New Chemical Entities (NCE) entries or Generic (early) entries to specific markets globally. Understanding these significant market changes is a precondition to understand the value of individual markets or companies over time, and in due time.

In order to identify and understand these issues, detailed insights to the key drivers are necessary. We identify these as four basic pillars: vertical structures (value chains / upstream partnerships), regulatory issues (eligibility: certifications and granted licenses), clinical issues (preconditioning proof of concept and regulatory options), and patent issues (demarcation of markets and quality signals). Based on this approach we believe that we are able to provide highly predictive as well as real time insights to basic market value changes in the individual countries in the global market place.